Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-12-01
DOI
10.3389/fonc.2017.00283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)
- (2016) Muhammet A. Kaplan et al. Breast Care
- Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94
- (2016) Ephraim A. Ansa-Addo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
- (2016) Rachel A. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
- (2016) Michael B. Bernstein et al. Nature Reviews Clinical Oncology
- Emerging Strategies for Treating Brain Metastases from Breast Cancer
- (2015) David P. Kodack et al. CANCER CELL
- Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival
- (2015) Amelia J. Johnston et al. CELL
- Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis
- (2015) Genyuan Zhu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
- (2015) Antonio Martínez-Aranda et al. Oncotarget
- Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues
- (2014) Anna Sophie Berghoff et al. ACTA NEUROPATHOLOGICA
- Luminal Subtypes Predict Improved Survival Following Central Nervous System Metastasis in Patients With Surgically Managed Metastatic Breast Carcinoma
- (2014) Andrea L. Wiens et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis
- (2014) Volker Rudat et al. BMC CANCER
- A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers
- (2014) U. N. Lassen et al. CLINICAL CANCER RESEARCH
- Treatment and Prognosis of Breast Cancer Patients with Brain Metastases According to Intrinsic Subtype
- (2014) S. Kuba et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
- (2014) Felipe Ades et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients
- (2014) Man-Hsin Hung et al. PLoS One
- Endoplasmic Reticulum Chaperones and Oxidoreductases: Critical Regulators of Tumor Cell Survival and Immunorecognition
- (2014) Tomás Gutiérrez et al. Frontiers in Oncology
- Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
- (2013) J. Crown et al. ANNALS OF ONCOLOGY
- Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
- (2013) M. J. Engstrøm et al. BREAST CANCER RESEARCH AND TREATMENT
- Risk factors and survival outcomes in patients with brain metastases from breast cancer
- (2013) A. M. Minisini et al. CLINICAL & EXPERIMENTAL METASTASIS
- Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study
- (2013) M. Puig-Vives et al. GYNECOLOGIC ONCOLOGY
- Efficiency and prognosis of whole brain irradiation combined with precise radiotherapy on triple-negative breast cancer
- (2013) Bo Luo et al. Journal of Cancer Research and Therapeutics
- Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer
- (2013) Nicholas K. Howland et al. JOURNAL OF SURGICAL RESEARCH
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
- (2013) Nancy U Lin et al. LANCET ONCOLOGY
- Adjuvant Systemic Therapies in Breast Cancer
- (2013) Leonel F. Hernandez-Aya et al. SURGICAL CLINICS OF NORTH AMERICA
- Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy
- (2013) Karen A. Cadoo et al. Surgical Oncology Clinics of North America
- TWEAK and Fn14 in the Neurovascular Unit
- (2013) Manuel Yepes Frontiers in Immunology
- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer
- (2012) Shaheenah Dawood et al. CANCER
- Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
- (2012) Matthias Preusser et al. EUROPEAN JOURNAL OF CANCER
- Impact of Triple-Negative Phenotype on Prognosis of Patients With Breast Cancer Brain Metastases
- (2012) Zhiyuan Xu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival
- (2012) Mikiya Ishihara et al. ONCOLOGY
- Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel
- (2012) George Fountzilas et al. PLoS One
- Expression of Endoplasmic Reticulum Stress Proteins Is a Candidate Marker of Brain Metastasis in both ErbB-2+ and ErbB-2− Primary Breast Tumors
- (2011) Rebeca Sanz-Pamplona et al. AMERICAN JOURNAL OF PATHOLOGY
- A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments
- (2011) Yahong Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
- (2011) Aoife J. Lowery et al. BREAST CANCER RESEARCH AND TREATMENT
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search